To determine whether combination treatment with TRAIL and bortezomib (TRAIL/bortezomib) triggers apoptosis in HNSCC cell lines, 089 and 090 cells were analysed by flow cytometry at the indicated time points (Figure 1c). The gene discussed is TNFSF10; the disease is head and neck squamous cell carcinoma.